ReP USP - Resultado da busca

Artigo de periodico
Optimizing therapeutic drug monitoring in pregnant women: a critical literature review (2023)
Moreira, Fernanda de Lima ; Benzi, Jhohann Richard de Lima ; Pinto, Leonardo; Thomaz, Matheus de Lucca; Duarte, Geraldo ; Lanchote, Vera Lucia
Fonte: Therapeutic Drug Monitoring. Unidades: FMRP, FCFRP
Assuntos: ANTIMALÁRICOS, GRAVIDEZ, MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MOREIRA, Fernanda de Lima et al. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review. Therapeutic Drug Monitoring, v. 45, n. 2, p. 159-172, 2023Tradução . . Disponível em: https://doi.org/10.1097/FTD.0000000000001039. Acesso em: 30 set. 2024.
APA
Moreira, F. de L., Benzi, J. R. de L., Pinto, L., Thomaz, M. de L., Duarte, G., & Lanchote, V. L. (2023). Optimizing therapeutic drug monitoring in pregnant women: a critical literature review. Therapeutic Drug Monitoring, 45( 2), 159-172. doi:10.1097/FTD.0000000000001039
NLM
Moreira F de L, Benzi JR de L, Pinto L, Thomaz M de L, Duarte G, Lanchote VL. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 2): 159-172.[citado 2024 set. 30 ] Available from: https://doi.org/10.1097/FTD.0000000000001039
Vancouver
Moreira F de L, Benzi JR de L, Pinto L, Thomaz M de L, Duarte G, Lanchote VL. Optimizing therapeutic drug monitoring in pregnant women: a critical literature review [Internet]. Therapeutic Drug Monitoring. 2023 ; 45( 2): 159-172.[citado 2024 set. 30 ] Available from: https://doi.org/10.1097/FTD.0000000000001039
Artigo de periodico
Extemporaneous compounding: a possible trigger tool to detect potential health incidents (2022)
Toma, Marina Massae; Santana, Gabriel de Freitas; Nadai, Tales Rubens de ; Varallo, Fabiana Rossi ; Benzi, Jhohann Richard de Lima ; Mastroianni, Patrícia de Carvalho
Fonte: Current Drug Safety. Unidades: FOB, FCFRP
Assuntos: SEGURANÇA DO PACIENTE, FARMACOTERAPIA, EVENTO ADVERSO A MEDICAMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOMA, Marina Massae et al. Extemporaneous compounding: a possible trigger tool to detect potential health incidents. Current Drug Safety, v. 17, n. 3, p. 183-192, 2022Tradução . . Disponível em: https://doi.org/10.2174/1574886316666211014155946. Acesso em: 30 set. 2024.
APA
Toma, M. M., Santana, G. de F., Nadai, T. R. de, Varallo, F. R., Benzi, J. R. de L., & Mastroianni, P. de C. (2022). Extemporaneous compounding: a possible trigger tool to detect potential health incidents. Current Drug Safety, 17( 3), 183-192. doi:10.2174/1574886316666211014155946
NLM
Toma MM, Santana G de F, Nadai TR de, Varallo FR, Benzi JR de L, Mastroianni P de C. Extemporaneous compounding: a possible trigger tool to detect potential health incidents [Internet]. Current Drug Safety. 2022 ; 17( 3): 183-192.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1574886316666211014155946
Vancouver
Toma MM, Santana G de F, Nadai TR de, Varallo FR, Benzi JR de L, Mastroianni P de C. Extemporaneous compounding: a possible trigger tool to detect potential health incidents [Internet]. Current Drug Safety. 2022 ; 17( 3): 183-192.[citado 2024 set. 30 ] Available from: https://doi.org/10.2174/1574886316666211014155946
Artigo de periodico
Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli (2022)
Abichabki, Nathália de Lima Martins ; Zacharias, Luísa Vieira; Moreira, Natália Columbaro; Bellíssimo-Rodrigues, Fernando; Moreira, Fernanda L.; Benzi, Jhohann Richard de Lima ; Ogasawara, Tânia Mara Casare; Ferreira, Joseane Cristina; Ribeiro, Camila M.; Pavan, Fernando R.; Pereira, Leonardo Régis Leira; Brancini, Guilherme Thomaz Pereira; Braga, Gilberto Ubida Leite; Zuardi, Antonio Waldo; Hallak, Jaime Eduardo Cecilio ; Crippa, José Alexandre de Souza ; Lanchote, Vera Lucia ; Cantón, Rafael; Darini, Ana Lúcia da Costa ; Andrade, Leonardo Neves de
Fonte: Scientific Reports. Unidades: FMRP, FCFRP
Assuntos: CANABINOIDES, REPOSICIONAMENTO DE FÁRMACOS, RESISTÊNCIA MICROBIANA ÀS DROGAS, SINERGISMO DE DROGAS, TESTES DE SENSIBILIDADE MICROBIANA, BACTÉRIAS GRAM-NEGATIVAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ABICHABKI, Nathália de Lima Martins et al. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, v. 12, p. 1-15, 2022Tradução . . Disponível em: https://doi.org/10.1038/s41598-022-10393-8. Acesso em: 30 set. 2024.
APA
Abichabki, N. de L. M., Zacharias, L. V., Moreira, N. C., Bellíssimo-Rodrigues, F., Moreira, F. L., Benzi, J. R. de L., et al. (2022). Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. Scientific Reports, 12, 1-15. doi:10.1038/s41598-022-10393-8
NLM
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 set. 30 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Vancouver
Abichabki N de LM, Zacharias LV, Moreira NC, Bellíssimo-Rodrigues F, Moreira FL, Benzi JR de L, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JA de S, Lanchote VL, Cantón R, Darini AL da C, Andrade LN de. Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli [Internet]. Scientific Reports. 2022 ; 12 1-15.[citado 2024 set. 30 ] Available from: https://doi.org/10.1038/s41598-022-10393-8
Artigo de periodico
Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control (2021)
Costa, Ana Carolina Conchon ; Benzi, Jhohann Richard de Lima ; Yamamoto, Priscila Akemi ; Freitas, Maria Cristina Foss de ; Paula, Francisco Jose Albuquerque de ; Zanelli, Cleslei Fernando; Lauretti, Gabriela Rocha ; Moraes, Natália Valadares
Fonte: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Assuntos: FARMACOCINÉTICA, DIABETES MELLITUS, DOR, HIPERGLICEMIA, FARMACOLOGIA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Ana Carolina Conchon et al. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control. British Journal of Clinical Pharmacology, v. 87, n. 4, p. 1981-1989, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14594. Acesso em: 30 set. 2024.
APA
Costa, A. C. C., Benzi, J. R. de L., Yamamoto, P. A., Freitas, M. C. F. de, Paula, F. J. A. de, Zanelli, C. F., et al. (2021). Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control. British Journal of Clinical Pharmacology, 87( 4), 1981-1989. doi:10.1111/bcp.14594
NLM
Costa ACC, Benzi JR de L, Yamamoto PA, Freitas MCF de, Paula FJA de, Zanelli CF, Lauretti GR, Moraes NV. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1981-1989.[citado 2024 set. 30 ] Available from: https://doi.org/10.1111/bcp.14594
Vancouver
Costa ACC, Benzi JR de L, Yamamoto PA, Freitas MCF de, Paula FJA de, Zanelli CF, Lauretti GR, Moraes NV. Population pharmacokinetics of gabapentin in patients with neuropathic pain: lack of effect of diabetes or glycaemic control [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 4): 1981-1989.[citado 2024 set. 30 ] Available from: https://doi.org/10.1111/bcp.14594
Artigo de periodico-carta/editorial
Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] (2020)
Gonçalves, Paulo Vinícius Bernardes; Moreira, Fernanda de Lima; Benzi, Jhohann Richard de Lima ; Cavalli, Ricardo de Carvalho; Duarte, Geraldo; Lanchote, Vera Lucia
Fonte: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Assuntos: FARMACOCINÉTICA, TRABALHO DE PARTO INDUZIDO, HIPERTENSÃO NA GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes et al. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1002/jcph.1719. Acesso em: 30 set. 2024. , 2020
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Cavalli, R. de C., Duarte, G., & Lanchote, V. L. (2020). Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta]. The Journal of Clinical Pharmacology. Hoboken: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. doi:10.1002/jcph.1719
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.[citado 2024 set. 30 ] Available from: https://doi.org/10.1002/jcph.1719
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Cavalli R de C, Duarte G, Lanchote VL. Nonrelevant pharmacokinetic drug-drug interaction between furosemide and pindolol enantiomers in hypertensive parturient women [Carta] [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 11): 1527-1529.[citado 2024 set. 30 ] Available from: https://doi.org/10.1002/jcph.1719
Artigo de periodico
A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section (2020)
Gonçalves, Paulo Vinícius Bernardes; Moreira, Fernanda de Lima; Benzi, Jhohann Richard de Lima ; Duarte, Geraldo; Lanchote, Vera Lucia
Fonte: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Assuntos: LÍQUIDO AMNIÓTICO, FÁRMACOS DIURÉTICOS, GRAVIDEZ, TRABALHO DE PARTO INDUZIDO, HIPERTENSÃO NA GRAVIDEZ, CESÁREA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GONÇALVES, Paulo Vinícius Bernardes et al. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, v. 60, n. 12, p. 1655-1661, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1681. Acesso em: 30 set. 2024.
APA
Gonçalves, P. V. B., Moreira, F. de L., Benzi, J. R. de L., Duarte, G., & Lanchote, V. L. (2020). A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section. The Journal of Clinical Pharmacology, 60( 12), 1655-1661. doi:10.1002/jcph.1681
NLM
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.[citado 2024 set. 30 ] Available from: https://doi.org/10.1002/jcph.1681
Vancouver
Gonçalves PVB, Moreira F de L, Benzi JR de L, Duarte G, Lanchote VL. A pilot study of the maternal-fetal pharmacokinetics of furosemide in plasma, urine, and amniotic fluid of hypertensive parturient women under cesarean section [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 12): 1655-1661.[citado 2024 set. 30 ] Available from: https://doi.org/10.1002/jcph.1681
Artigo de periodico
Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations (2020)
Costa, Ana Carolina Conchon; Yamamoto, Priscila Akemi; Lauretti, Gabriela Rocha; Benzi, Jhohann Richard de Lima ; Zanelli, Cleslei Fernando ; Barz, Vivien; Ciarimboli, Giuliano; Moraes, Natália Valadares de
Fonte: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Assuntos: FARMACOCINÉTICA, ANTI-HISTAMÍNICOS, ANTICONVULSIVANTES, DOR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Ana Carolina Conchon et al. Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations. The Journal of Clinical Pharmacology, v. 60, n. 8, p. 1076-1086, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcph.1603. Acesso em: 30 set. 2024.
APA
Costa, A. C. C., Yamamoto, P. A., Lauretti, G. R., Benzi, J. R. de L., Zanelli, C. F., Barz, V., et al. (2020). Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations. The Journal of Clinical Pharmacology, 60( 8), 1076-1086. doi:10.1002/jcph.1603
NLM
Costa ACC, Yamamoto PA, Lauretti GR, Benzi JR de L, Zanelli CF, Barz V, Ciarimboli G, Moraes NV de. Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 8): 1076-1086.[citado 2024 set. 30 ] Available from: https://doi.org/10.1002/jcph.1603
Vancouver
Costa ACC, Yamamoto PA, Lauretti GR, Benzi JR de L, Zanelli CF, Barz V, Ciarimboli G, Moraes NV de. Cetirizine reduces gabapentin plasma concentrations and effect: role of renal drug transporters for organic cations [Internet]. The Journal of Clinical Pharmacology. 2020 ; 60( 8): 1076-1086.[citado 2024 set. 30 ] Available from: https://doi.org/10.1002/jcph.1603

Unidades USP

ReP

Filtros

Departamento

Autores

Autores USP

Assuntos

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada